Genscript Biotech Corporation (HKG:1548)

Genscript Biotech Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	30,106	21,097	42,166	52,563	72,496	22,033
Market Cap Growth	41.90%	-49.97%	-19.78%	-27.50%	229.03%	-33.64%
Enterprise Value	27,088	18,906	38,022	47,670	64,744	14,836
Last Close Price	13.77	9.84	19.86	24.85	34.50	11.28
PE Ratio	1.23	0.92	-	-	-	-
Forward PE	49.46	-	-	-	-	-
PS Ratio	4.63	4.57	9.63	10.77	18.97	7.27
PB Ratio	0.87	0.63	2.64	4.95	6.70	3.48
P/TBV Ratio	0.87	0.63	3.94	6.85	9.25	3.30
P/FCF Ratio	29.88	-	-	-	-	-
P/OCF Ratio	16.79	35.90	-	-	-	-
PEG Ratio	-	2.52	2.52	2.52	2.52	2.52
EV/Sales Ratio	4.17	4.09	8.68	9.77	16.94	4.90
EV/EBITDA Ratio	186.34	34.75	58.29	-	-	-
EV/EBIT Ratio	-	262.23	185.81	-	-	-
EV/FCF Ratio	26.88	-	-	-	-	-
Debt / Equity Ratio	0.12	0.17	0.41	0.48	0.30	0.07
Debt / EBITDA Ratio	2.20	8.51	8.59	-	-	-
Debt / FCF Ratio	4.27	-	-	-	-	-
Asset Turnover	0.19	0.14	0.19	0.26	0.27	0.34
Inventory Turnover	8.23	7.64	5.12	6.17	5.46	5.60
Quick Ratio	1.78	2.46	4.50	2.99	3.80	2.85
Current Ratio	1.96	2.72	4.76	3.23	3.97	3.03
Return on Equity (ROE)	-1.94%	-5.46%	9.56%	-31.12%	-47.05%	-47.38%
Return on Assets (ROA)	2.56%	0.13%	0.55%	-11.45%	-12.88%	-10.94%
Return on Invested Capital (ROIC)	4.45%	0.34%	3.34%	-91.80%	-152.50%	-600.56%
Return on Capital Employed (ROCE)	3.70%	0.20%	0.90%	-21.90%	-20.80%	-18.30%
Earnings Yield	81.13%	109.05%	-1.77%	-3.36%	-3.86%	-7.21%
FCF Yield	3.35%	-4.42%	-9.99%	-4.99%	-2.90%	-9.61%
Buyback Yield / Dilution	-4.08%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%
Total Shareholder Return	-4.08%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.